The pharmacological targeting of ROCK has been evaluated in rats infused with Ang II: the simultaneous treatment with fasudil, a ROCK inhibitor, significantly suppressed the Ang II-induced left ventricular hypertrophy and cardiomyocyte hypertrophy [31]. Here, AGT is linked to left ventricular hypertrophy.